These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25771509)

  • 1. Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset.
    Kornum BR; Pizza F; Knudsen S; Plazzi G; Jennum P; Mignot E
    Brain Behav Immun; 2015 Oct; 49():54-8. PubMed ID: 25771509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ?
    Lecendreux M; Libri V; Jaussent I; Mottez E; Lopez R; Lavault S; Regnault A; Arnulf I; Dauvilliers Y
    J Autoimmun; 2015 Jun; 60():20-31. PubMed ID: 25892508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study.
    Dauvilliers Y; Jaussent I; Lecendreux M; Scholz S; Bayard S; Cristol JP; Blain H; Dupuy AM
    Brain Behav Immun; 2014 Mar; 37():260-6. PubMed ID: 24394344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
    Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
    Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy.
    Lopez R; Barateau L; Evangelista E; Chenini S; Robert P; Jaussent I; Dauvilliers Y
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
    Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
    J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
    Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
    Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy.
    Heier MS; Skinningsrud A; Paus E; Gautvik KM
    Sleep Med; 2014 Jun; 15(6):614-8. PubMed ID: 24784789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
    Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination.
    van der Heide A; Hegeman-Kleinn IM; Peeters E; Lammers GJ; Fronczek R
    J Neuroimmunol; 2015 Jun; 283():58-62. PubMed ID: 26004157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired histaminergic neurotransmission in children with narcolepsy type 1.
    Franco P; Dauvilliers Y; Inocente CO; Guyon A; Villanueva C; Raverot V; Plancoulaine S; Lin JS
    CNS Neurosci Ther; 2019 Mar; 25(3):386-395. PubMed ID: 30225986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease.
    Moresco M; Lecciso M; Ocadlikova D; Filardi M; Melzi S; Kornum BR; Antelmi E; Pizza F; Mignot E; Curti A; Plazzi G
    Sleep Med; 2018 Apr; 44():53-60. PubMed ID: 29530370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Narcolepsy: From the discovery of a wake promoting peptide to autoimmune T cell biology and molecular mimicry with flu epitopes].
    Ravel JM; Mignot EJM
    Biol Aujourdhui; 2019; 213(3-4):87-108. PubMed ID: 31829930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
    Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
    Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.
    Dauvilliers Y; Delallée N; Jaussent I; Scholz S; Bayard S; Croyal M; Schwartz JC; Robert P
    Sleep; 2012 Oct; 35(10):1359-66. PubMed ID: 23024434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.